The neurospan bridge: a device for peripheral nerve repair - peripheral nerve injury (PNI) occurs in 3% of all trauma cases and 30% of combat injuries to the extremities, resulting in a loss of five…
Active Cooperative Agreement Awarded Last action
- Award ID
- U44NS128489
- Recipient
-
Auxilium Biotechnologies Inc. UEI JDR1KPU6KZX8
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,094,464
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date 81% complete
- Originally
- Place of performance
- Ann Arbor, MI 48103, USA
Award details come from USAspending.gov.
Description
The neurospan bridge: a device for peripheral nerve repair - peripheral nerve injury (PNI) occurs in 3% of all trauma cases and 30% of combat injuries to the extremities, resulting in a loss of five million working days each year and costs of $150 billion annually in the U.S. The standard of care in the clinic is a nerve autograft from the patients' leg. The neurospan bridge is a unique, biomimetic, multi-channel scaffold that maintains linearity throughout the structure, thus accelerating and guiding regenerating axons precisely to their targets on the distal end of the transected nerve. IT has been extensively tested in gaps up to 3CM-long and demonstrated superiority to existing devices in a short-GAP animal model, and superiority to nerve autograft in a long-GAP animal model. This project will put in place a program to finalize pre-clinical studies, submit an IDE application to the FDA and carry out a feasibility clinical study followed by 510(k) application. The proposed project brings together experts in peripheral nerve injury, axonal regeneration, neurology, neurosurgery and bioengineering to develop a practical, cost-effective, consistent, and transnationally relevant medical device for the treatment of peripheral nerve injury.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,500,000 | |
| Amendment | $94,464 | |
| Amendment | $0 | |
| Amendment | $500,000 | |
| Amendment | $1,000,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,000,000 | |
| Original award | $1,000,000 |
Quick answers
Who received award U44NS128489?
U44NS128489 was awarded to Auxilium Biotechnologies Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on March 15, 2023.
How much is award U44NS128489 worth?
$5,094,464 has been obligated on U44NS128489.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award